Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Treatment Study Protocol of the ALLTogether Consortium for Infants, Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL): a Pilot Study

NCT03911128 is registered in ClinicalTrials.gov with Mats Heyman as lead sponsor.

NCT NCT03911128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03911128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Treatment Study Protocol of the ALLTogether Consortium for Infants, Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL): a Pilot Study
Lead sponsor
Mats Heyman
Phase
Observational
Overall status
Recruiting
Start date
August 29, 2019
Completion date
June 30, 2033
Enrollment
500 (estimated)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, acute lymphoblastic